With the COVID-19 outbreak intensifying, a company on the forefront of treatment is leading the S&P 500. | Image: Gilead…
Regeneron
This Biotech Stock Is Surging Over Potential COVID-19 Drug
U.S. biotech Regeneron has some promising developments around its new COVID-19 drug. | Image: Lizabeth MENZIES / Centers for Disease…